bioRxiv ScienceSearch

Biology subjects

Rieblinger, B.

Publications and source records attributed to Rieblinger, B..

2 recordsLinked to original sources

Porcine model elucidates function of p53 isoform in carcinogenesis

BackgroundThe pig has long been an important animal species for biomedical research. Recent years has also seen an increasing number of genetically engineered pig models of human diseases including cancer. We previously generated pigs with a modified TP53 allele which carries a Cre-removable transcriptional stop signal in intron 1, and an oncogenic mutation TP53R167H (orthologous to human TP53R175H and mouse Trp53R172H) in exon 5. Pigs with the unrecombined mutant allele (flTP53R167H) develop osteosarcoma (OS) in aged heterozygous and young homozygous animals. In addition, some homozygous animals also developed nephroblastomas and lymphomas. This observation suggested that TP53 gene dysfunction is itself the key initiator of tumorigenesis, but raises the question which aspects of the TP53 regulation leads to the development of such a narrow tumour spectrum, mainly OS. MethodsWe performed a series of molecular and cellular analyses to study the regulation of TP53 and its family members in both healthy tissue and tumours (n= 48) from flTP53R167H pigs. Human OS cell lines were used to prove relevance to human patients. ResultsMolecular analyses of p53 revealed the presence of two internal TP53 promoters (Pint and P2) equivalent to those found in human. Consequently, both pigs and human express TP53 isoforms. Data presented here strongly suggest that P2-driven expression of the mutant R167H-{Delta}152p53 isoform (equivalent to the human R175H-{Delta}160p53 isoform) and its circular counterpart circTP53 determine the tumour spectrum and play a critical role in the malignant transformation of bones, kidney or spleen in flTP53R167H pigs. The detection of {Delta}152p53 isoform mRNA in serum is indicative of tumorigenesis. Furthermore, we showed a tissue-specific p53-dependent deregulation of the p63 and p73 isoforms in these tumours. ConclusionsThis study highlights important species-specific differences in the transcriptional regulation of TP53. For the first time a circTP53 RNA was identified. Results indicate that the {Delta}152p53 isoform, its circular circTP53 and p53 family members, TAp63{delta} and TAp73{delta}, likely play a role in the malignant transformation of bone and other tumours. Considering the similarities of TP53 regulation between pig and human, these observations provide useful pointers for further investigation into isoform function including the novel circTP53 in both the pig model and human patients.

cancer biology

Resources for genome editing in livestock: Cas9-expressing chickens and pigs

Genetically modified animals continue to provide important insights in biomedical sciences. Research has focused mostly on genetically modified mice so far, but other species like pigs resemble more closely the human physiology. In addition, cross-species comparisons with phylogenetically distant species such as chickens provide powerful insights into fundamental biological and biomedical processes. One of the most versatile genetic methods applicable across species is CRISPR/Cas9. Here, we report for the first time the generation of Cas9 transgenic chickens and pigs that allow in vivo genome editing in these two important agricultural species. We demonstrated that Cas9 is constitutively expressed in all organs of both species and that the animals are healthy and fertile. In addition, we confirmed the functionality of Cas9 for a number of different target genes and for a variety of cell types. Taken together, these transgenic animal species expressing Cas9 provide an unprecedented tool for agricultural and biomedical research, and will facilitate organ specific reverse genetics as well as cross-species comparisons. Significance statementGenome engineering of animals is crucial for translational medicine and the study of genetic traits. Here, we generated transgenic chickens and pigs that ubiquitously express the Cas9 endonuclease, providing the basis for in vivo genome editing. We demonstrated the functionality of this system by successful genome editing in chicken and porcine cells and tissues. These animals facilitate organ specific in vivo genome editing in both species without laborious germ line modifications, which will reduce the number of animals needed for genetic studies. They also provide a new tool for functional genomics, developmental biology and numerous other applications in biomedical and agricultural science.

molecular biology